毛螺菌科
人参
蔷薇花
肠道菌群
链脲佐菌素
益生元
人参皂甙
2型糖尿病
糖尿病
乳酸菌
成分
胰岛素抵抗
生物
药理学
食品科学
医学
内分泌学
生物化学
发酵
替代医学
病理
基因
厚壁菌
16S核糖体RNA
作者
Man Peng,Liming Wang,Hui Su,Lei Zhang,Yue Yang,Le Sun,Yi Wu,Lei Ran,Sida Liu,Min Yin,Shu-De Li,Wei‐Xun Chunyu
摘要
Ginsenoside Rg1 is the active ingredient of the plant named genus Panax (ginseng), which exhibited significant bioactivities, including anti-inflammatory, antioxidation, and anti-diabetic effects. Herein, 4-week treatment of ginsenoside Rg1 remarkably decreased blood glucose levels and improved the resistance of insulin, oxidative stress, and inflammation along with lipid profile in T2D rats triggered via high-fat diet and streptozotocin (STZ). Ginsenoside Rg1 supplementation improved the intestinal microbial composition induced by type 2 diabetes (T2D), which increased the proportions of Lachnospiraceae_NK4A136_group and Lachnoclostridium and decreased the proportions of Lactobacillus. Additionally, Spearman's correlation test between the gut microflora and biomedical assays (|r| > .5) revealed that the Lachnospiraceae_NK4A136_group, Roseburia, and Romboutsia greatly affect intestinal microbiota, which may play pivotal roles in preventing T2D. Our findings illustrate the use of ginsenoside Rg1 as a dietary supplement along with prospective prebiotics due to its ability to alter the gut microflora and alleviate T2D-linked biochemical abnormalities. Practical applications This was the first study to elucidate the influences of ginsenosides Rg1 in improving the intestinal microbiota of T2D in SD rats. The data illustrated that the ginsenosides Rg1 remarkably increased the proportions of SCFAs producing bacteria. Hence, ginsenoside Rg1 could be used as a potential prebiotic in the treatment of T2D through alteration of intestinal microbiota.
科研通智能强力驱动
Strongly Powered by AbleSci AI